Cancer Immunology
Cancer Immunology refers to the relationship between immune function and cancer. The immunological mechanisms involved in cancer growth are highly complex and provide numerous potential points for intervention with small molecules, including extracellular enzymes, receptors and intracellular signal transduction pathways.
Cancer Immunology Products Targets
- STAT (10)
- PI 3-kinase (22)
- NTPDase (4)
- JAK (10)
- Adenosine A2B Receptor (7)
- Adenosine A2A Receptor (11)
- Toll-like Receptor (11)
- TGF-β Receptor (9)
- STING-Dependent Signaling (1)
- Others (7)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- Purinergic (P2Y) Receptor (31)
- Purinergic (P2X) Receptor (32)
- Prostanoid Receptor (24)
Products for Cancer Immunology - Page 12
- Cat.No. Product Name Information/Activity
-
BCC7514
MRS 2690
15039-58-4
-
BCC7386
MRS 2693 trisodium salt
1448858-83-0
-
BCC7800
MRS 2768 tetrasodium salt
1047980-83-5
-
BCC6133
MRS 2957 triethylammonium salt
1228271-30-4
-
BCC6134
MRS 4062 triethylammonium salt
1309871-50-8
-
BCC7804
NF 546
NF546 is a selective non-nucleotide P2Y11 agonist with a pEC50 of 6.27. NF546 stimulates release of interleukin-8 from human monocyte-derived dendritic cells.
-
BCC6153
5-OMe-UDP trisodium salt
Potent P2Y<sub>6</sub> agonist
-
BCC7459
PSB 0474
917567-60-3
-
BCC7625
2-ThioUTP tetrasodium salt
1343364-70-4
-
BCC7624
UTPγS trisodium salt
1266569-94-1
